Endo Pharmaceuticals

SUPPRELIN® LA

histrelin acetate subcutaneous implant, A once-yearly LHRH agonist implant providing continuous therapy for the treatment of central precocious puberty (CPP) in children.

Annual Implant for Central Precocious Puberty

SUPPRELIN® LA is a small subcutaneous implant inserted in the upper arm that continuously releases histrelin acetate, an LHRH agonist, over 12 months. It provides a convenient, injection-free treatment option for children with central precocious puberty.

  • Once-yearly subcutaneous implant
  • Provides 12 months of continuous LHRH agonist therapy
  • Eliminates the need for frequent injections
  • Proven suppression of gonadotropins in CPP
  • Patient and parent education resources available
1×

Per Year

Annual subcutaneous implant

No Daily or Monthly Injections
Continuous therapy from a single annual procedure

Patient & Clinical Resources

Back to Growth Disorders
Traveling with your medication? This medication requires refrigeration. Our partner 4AllFamily offers insulin coolers and medical travel cases to keep your medication safe wherever you go.
Shop Now

Questions About SUPPRELIN® LA?

Contact our clinical team for information on insurance coverage, patient support resources, and the implant process.